POLQ and cancer: It will be interesting to inspect cancer genomes, especially those evolving in cancer cells that are characterized by a defect in homologous recombination for genomic scars that carry the signature of POLQ-mediated end joining, to also determine the contribution of this mutagenic pathway to tumorigenesis.